Inhibitory effects of human aortic and venous acid glycosaminoglycans on thrombus formation.
D000328:Adult; D001013:Aorta, Thoracic / Q000032:analysis; D001161:Arteriosclerosis / Q000209:etiology; D001344:Autopsy; D001777:Blood Coagulation / Q000187:drug effects*; D002807:Chondroitin / Q000302:isolation & purification / Q000494:pharmacology; D004586:Electrophoresis; D005260:Female; D006025:Glycosaminoglycans / Q000302:isolation & purification / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008722:Methods; D013927:Thrombosis / Q000150:complications; D013997:Time Factors; D014682:Vena Cava, Inferior / Q000032:analysis; D014683:Vena Cava, Superior / Q000032:analysis
D006025:Glycosaminoglycans; D002807:Chondroitin